Header cover image
  • Investing Ideas
  • /
  • Norwegian Pharmaceuticals & Biotech Sustainable Track Record

Norwegian Pharmaceuticals & Biotech Sustainable Track Record

Results

1

0 new

Companies which have reinvested earnings to sustain 10% yearly growth over 5 years.

1 companies

Vistin Pharma

Market Cap: NOK 1.2b

Through its subsidiary, Vistin Pharma AS, engages in the production and sale of active pharmaceutical ingredients (APIs) worldwide.

VISTN

NOK 26.00

7D

5.7%

1Y

18.2%